The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
1-(2-((2-((3-chloro-2-fluorobenzyl)amino)-2-oxoethyl)(cyclopropyl)amino)-2-oxoethyl)-5-(4-(4-fluorobenzyl)piperazine-1-carboxamido)-1H-indazole-3-carboxamide ID: ALA5219562
PubChem CID: 130300248
Max Phase: Preclinical
Molecular Formula: C34H35ClF2N8O4
Molecular Weight: 693.16
Associated Items:
Names and Identifiers Canonical SMILES: NC(=O)c1nn(CC(=O)N(CC(=O)NCc2cccc(Cl)c2F)C2CC2)c2ccc(NC(=O)N3CCN(Cc4ccc(F)cc4)CC3)cc12
Standard InChI: InChI=1S/C34H35ClF2N8O4/c35-27-3-1-2-22(31(27)37)17-39-29(46)19-44(25-9-10-25)30(47)20-45-28-11-8-24(16-26(28)32(41-45)33(38)48)40-34(49)43-14-12-42(13-15-43)18-21-4-6-23(36)7-5-21/h1-8,11,16,25H,9-10,12-15,17-20H2,(H2,38,48)(H,39,46)(H,40,49)
Standard InChI Key: BEQIHGYSIRUYPP-UHFFFAOYSA-N
Molfile:
RDKit 2D
49 54 0 0 0 0 0 0 0 0999 V2000
-5.4170 1.2604 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-4.8337 1.8438 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.0368 1.6302 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.8233 0.8333 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-4.4066 0.2500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-5.2035 0.4635 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.0264 0.6199 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.8128 -0.1769 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-2.4430 1.2032 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-1.6461 0.9897 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.4259 0.1912 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.6269 -0.0115 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.2425 -0.7315 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.6498 -1.4490 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.4746 -1.4551 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-0.2320 -2.1605 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
0.5717 -0.6005 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
0.6929 0.1913 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-0.0520 0.5741 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.2713 1.3694 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.0670 1.5770 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.4044 0.6091 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.1219 0.2019 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.1280 -0.6230 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
2.8333 0.6196 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
3.5508 0.2124 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.2622 0.6301 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.9797 0.2229 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
5.6912 0.6407 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.4086 0.2333 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.4147 -0.5950 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.1342 -0.9979 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.8413 -0.5808 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.8352 0.2443 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.1202 0.6510 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.1142 1.4760 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
8.5467 0.6621 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
4.2561 1.4551 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
2.8333 1.4446 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.2466 2.1605 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.4216 2.1596 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-6.2140 1.4740 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-6.7973 0.8906 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-6.5840 0.0936 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-7.1662 -0.4874 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-7.9633 -0.2738 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-8.1773 0.5185 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-7.5977 1.1051 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-8.5467 -0.8572 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
2 1 1 0
3 2 1 0
4 3 1 0
5 4 1 0
6 5 1 0
1 6 1 0
7 4 1 0
7 8 2 0
9 7 1 0
10 9 1 0
10 11 1 0
11 12 2 0
12 13 1 0
13 14 1 0
14 15 1 0
14 16 2 0
13 17 2 0
18 17 1 0
19 18 1 0
12 19 1 0
19 20 2 0
20 21 1 0
21 10 2 0
18 22 1 0
22 23 1 0
23 24 2 0
23 25 1 0
25 26 1 0
26 27 1 0
27 28 1 0
28 29 1 0
29 30 1 0
30 31 1 0
31 32 2 0
32 33 1 0
33 34 2 0
34 35 1 0
35 30 2 0
35 36 1 0
34 37 1 0
27 38 2 0
39 25 1 0
39 40 1 0
40 41 1 0
39 41 1 0
1 42 1 0
42 43 1 0
44 43 2 0
45 44 1 0
46 45 2 0
47 46 1 0
48 47 2 0
43 48 1 0
46 49 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Topical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 693.16Molecular Weight (Monoisotopic): 692.2438AlogP: 3.72#Rotatable Bonds: 11Polar Surface Area: 145.90Molecular Species: NEUTRALHBA: 7HBD: 3#RO5 Violations: 1HBA (Lipinski): 12HBD (Lipinski): 4#RO5 Violations (Lipinski): 2CX Acidic pKa: 12.93CX Basic pKa: 6.21CX LogP: 2.67CX LogD: 2.65Aromatic Rings: 4Heavy Atoms: 49QED Weighted: 0.22Np Likeness Score: -2.19
References 1. Zhang W, Wu M, Vadlakonda S, Juarez L, Cheng X, Muppa S, Chintareddy V, Vogeti L, Kellogg-Yelder D, Williams J, Polach K, Chen X, Raman K, Babu YS, Kotian P.. (2022) Scaffold hopping via ring opening enables identification of acyclic compounds as new complement Factor D inhibitors., 74 [PMID:36272185 ] [10.1016/j.bmc.2022.117034 ]